| Literature DB >> 25610771 |
K Caeyenberghs1, H W R Powell2, R H Thomas3, L Brindley4, C Church5, J Evans4, S D Muthukumaraswamy4, D K Jones4, K Hamandi6.
Abstract
OBJECTIVE: Juvenile myoclonic epilepsy (JME) is a common idiopathic (genetic) generalized epilepsy (IGE) syndrome characterized by impairments in executive and cognitive control, affecting independent living and psychosocial functioning. There is a growing consensus that JME is associated with abnormal function of diffuse brain networks, typically affecting frontal and fronto-thalamic areas.Entities:
Keywords: Diffusion MRI; Epilepsy; Graph theory; Neuropsychology; Structural connectivity
Mesh:
Year: 2014 PMID: 25610771 PMCID: PMC4299970 DOI: 10.1016/j.nicl.2014.11.018
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Summary of demographic characteristics.
| Demographic data | JME patients ( | Controls ( |
|---|---|---|
| Age (years) | 26.8 ± 7.8 | 28.5 ± 7.7 |
| Sex (F:M) | 25:10 | 25:9 |
| Seizure semiology | MJ 82% | − |
| Age at onset | 15 ± 3.5 | − |
| EEG | PPR 34 % | − |
| Duration of epilepsy | 15.2 ± 8.8 | − |
| AED | Monotherapy 43% |
Abbreviations: PPR — photoparoxysmal response, GSW — generalized spike wave, LEV — levetiracetam, VPA — sodium valproate, LTG — lamotrigine, ZNM — zonisamide, TPM — topiramate, CLB — clobazam.
Fig. 1Cortical and subcortical regions (58 in each hemisphere; 116 in total) as anatomically defined by a prior template image (the AAL template) in standard stereotaxic space.
Neuropsychometric characteristics of the 14 individuals who underwent cognitive testing. *Significant at p = 0.05, **Significant after strict Bonferroni correction.
| Significant | ||||
|---|---|---|---|---|
| 98.6 | (69-122) | 0.3821 | ||
| 98.5 | (74-125) | 0.3356 | ||
| 98.0 | (69-131) | 0.2053 | ||
| 95.9 | (76-122) | 0.0174 | * | |
| 97.6 | (73-117) | 0.1294 | ||
| 100.4 | (89-123) | 0.7796 | ||
| 91.8 | (75-106) | 0.0001 | ** | |
| 103.1 | (86-132) | 0.0563 | ||
| 92.1 | (68-115) | 0.0002 | ** | |
| 9.1 | (4-14) | 0.0135 | * | |
| 9.4 | (3-15) | 0.5099 | ||
| 9.4 | (5-14) | 0.5288 | ||
| 7.8 | (3-12) | 0.0424 | * | |
| 7.5 | (1-13) | 0.0232 | * | |
| 10.4 | (6-14) | 0.6589 | ||
| 64.5 | (5-100) | n/a | ||
| 3.6 | (2-4) | 0.9784 | ||
| 3.1 | (1-4) | 0.5745 | ||
| 2.0 | (0-4) | 0.5544 | ||
| 1.7 | (0-4) | 0.5112 | ||
| 16.0 | (10.5-22.5) | 0.0135 | * | |
| 51.7 | (43-58) | 0.0001 | ** | |
Fig. 2The bivariate method identified one subnetwork consisting of 8 nodes and 7 connections, which demonstrated significantly increased connectivity in patients with JME (lower panel) compared to the control group (upper panel). The edge widths represent the number of tracts between nodes. The figure is made in ExploreDTI ().
Fig. 3Group results (mean and standard deviation) of the streamline counts for JME patients and controls in each of the connections comprising the implicated subnetwork.